Cerivastatin (Baycol, Lipobay) Controversy

Cerivastatin (also commonly referred to by its brand names Baycol or Lipobay) was a synthetic statin that was used as a cholesterol-lowering medication. Baycol was created by Bayer, a prominent pharmaceutical and chemical company based in Germany. Baycol was created in order to compete against Pfizer’s popular atorvastatin (Lipitor). It was launched in 1998 and was taken off the market in 2001. Between its release and recall, more than 10 million prescriptions were written for Baycol in the United States.


After three years on the market, Baycol was recalled due to rhabdomyolysis occurrence rates that were 16 to 86 times higher than other members of the statin family. Despite the fact that Baycol made up only 2.0 percent of all the statin prescriptions in the United ...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles